Y. Yoshimoto et al., Intraparenchymal and intrasylvian haematomas secondary to ruptured middle cerebral artery aneurysms: prognostic factors and therapeutic considerations, BR J NEUROS, 13(1), 1999, pp. 18-24
The aim of this study was to investigate prognostic factors and the most ap
propriate treatment for patients with ruptured middle cerebral artery (MCA)
aneurysms in relation to haematoma distribution. Ninety-two patients with
ruptured MCA aneurysms, who underwent surgery during the last 11 pars from
1986 to 1996, were assigned to one of the three groups according to the hae
matoma distribution. Group A comprised 17 patients who had an intraparenchy
mal haematoma (IPH) larger than 30 mm (maximum diameter) with or without su
barachnoid haemorrhage (SAH), group B comprised 24 patients having a dense
intra-Sylvian fissure haematoma (ISH) larger than 30 mm (maximum diameter)
and group C consisted of 52 patients having only diffuse SAH without a loca
lized dense haematoma. The clinical course and factors affecting the outcom
e of the patients in each group were investigated. Patients in groups A and
B had a more severe clinical grade on admission than those in group C. As
a result, patients in these two groups had a poorer outcome. In group C, in
dependent life was achieved for 98% of the patients. In group A, the clinic
al grade on admission and the diameter of the haematoma were significantly
correlated with outcome. Initial brain damage due to IPHs seemed to be the
main cause of disability, while only 7% developed delayed ischaemic neurolo
gical deficits (DIND). In group B, 54% of patients suffered from subsequent
brain oedema and DIND occurred in 50%. These factors were related to a poo
r outcome. The MCA aneurysms tend to have localized dense haematomas, as we
ll as diffuse SAH; the former seems to affect more on the course and outcom
e of the patients. Accurate assessment of the bleeding patterns in patients
with ruptured MCA aneurysms will be useful in helping us predict the clini
cal course and the most appropriate treatment for these individuals.